<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8-medicines-07-00057">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mannucci</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Navarra</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Calapai</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Spagnolo</surname>
    <given-names>E.V.</given-names>
   </name>
   <name>
    <surname>Busard√≤</surname>
    <given-names>F.P.</given-names>
   </name>
   <name>
    <surname>Cas</surname>
    <given-names>R.D.</given-names>
   </name>
   <name>
    <surname>Ippolito</surname>
    <given-names>F.M.</given-names>
   </name>
   <name>
    <surname>Calapai</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Neurological Aspects of Medical Use of Cannabidiol</article-title>
  <source>CNS Neurol. Disord. Drug Targets</source>
  <year>2017</year>
  <volume>16</volume>
  <fpage>541</fpage>
  <lpage>553</lpage>
  <pub-id pub-id-type="doi">10.2174/1871527316666170413114210</pub-id>
  <pub-id pub-id-type="pmid">28412918</pub-id>
 </element-citation>
</ref>
